Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Philip Bath

Stroke Association Professor of Stroke Medicine

University of Nottingham

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

70%

Neurology

50%

Ischemic Stroke

70%

Cerebrovascular Disease

50%

Thrombosis

40%

Coronary Artery Disease

40%

Ischemic Medicine

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Pharyngeal Electrical stimulation for Acute Stroke dysphagia Trial (PhEAST)

Open Date: 2022-01-01

Close Date: 2025-03-31

Grant: Close

PROphylactic TrEatment of COVID in Care Homes Trial (PROTECT)

Open Date: 2021-01-01

Close Date: 2022-12-31

Grant: Close

MICA: Efficacy and safety evaluation of AZD1236 (Matrix metalloproteinase 9 & 12 inhibitor) in experimental stroke

Open Date: 2017-11-20

Close Date: 2020-11-19

Grant: Close

An exploration of the application of non-invasive cerebellar stimulation in the neurorehabilitation of dysphagia after stroke

Open Date: 2017-07-06

Close Date: 2020-10-05

Grant: Close

Interventions for deliberately altering blood pressure in acute stroke

Open Date: 2013-11-01

Close Date: 2014-10-31

Articles30

Effect of history of hypertension on efficacy of clopidogrel-aspirin in ischemic stroke

Article Link

Year:

2025

Preclinical Ischemic Stroke Multicenter (PRISM) Trials Collective Statement: Opportunities, Challenges, and Recommendations for a New Era

Article Link

Year:

2025

Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposing

Article Link

Year:

2025

Polypill and RiskOMeter to Prevent StrOke and CogniTive ImpairmEnt in Primary Health Care (PROMOTE) Randomized Clinical Trial: Rationale and Design

Article Link

Year:

2025

Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack

Article Link

Year:

2025

Relationship Between Neutrophil Count and 90‐Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial

Article Link

Year:

2025

Age and effect of intensive statin in acute mild ischemic stroke or transient ischemic attack: Subgroup analysis of the INSPIRES trial

Article Link

Year:

2025

Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial

Article Link

Year:

2025

Lessons from the PROTECT-CH COVID-19 platform trial in care homes

Article Link

Year:

2025

The hazards of chasing subgroups in neutral stroke trials

Article Link

Year:

2025

Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack

Article Link

Year:

2024

Comorbidities and Angiogenic Regulators Affect Endothelial Progenitor Cell Subtype Numbers in a Healthy Volunteer Control Group

Article Link

Year:

2024

Challenges and Experiences in Multicenter Prehospital Stroke Research: Narrative Data from the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial-2 (RIGHT-2)

Article Link

Year:

2024

Metoclopramide to Prevent Pneumonia in Patients With Stroke and a Nasogastric Tube: Data From the PRECIOUS Trial

Article Link

Year:

2024

Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial

Article Link

Year:

2024

Statistical Analysis Plan for the INTEnsive Ambulance-Delivered Blood Pressure Reduction in Hyper-ACute Stroke Trial

Article Link

Year:

2024

Remote Ischemic Conditioning for Secondary Stroke Prevention

Article Link

Year:

2024

Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)

Article Link

Year:

2024

One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial

Article Link

Year:

2024

Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial

Article Link

Year:

2024

Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure

Article Link

Year:

2023

Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial

Article Link

Year:

2023

A systematic review of ambulance service-based randomised controlled trials in stroke

Article Link

Year:

2023

Accuracy of artificial intelligence software for CT angiography in stroke

Article Link

Year:

2023

Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia.

Article Link

Year:

2023

Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.

Article Link

Year:

2023

Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial.

Article Link

Year:

2023

Antiplatelet Therapy in Neurointervention

Article Link

Year:

2023

Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.

Article Link

Year:

2023

Can all healthy adults use the current evidential breath alcohol analysers? An investigation using a large spirometry database.

Article Link

Year:

2023

Collaborators20

Márcio Augusto Diniz

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

Xiaoying Chen

The George Institute for Global Health

AUSTRALIA

Joanna Wardlaw

Professor of Applied Neuroimaging and Honorary Consultant Neuroradiologist

UNITED KINGDOM

Jason Appleton

Honorary Assistant Professor

University of Nottingham

UNITED KINGDOM

Rüdiger von Kummer

Professor

Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden

GERMANY

Kailash Krishnan

University of Nottingham

UNITED KINGDOM

Philip White

Professor of Interventional and Diagnostic Neuroradiology

Newcastle University

UNITED KINGDOM

Thompson Robinson

Professor of Stroke Medicine

University of Leicester

UNITED KINGDOM

Dr Othman Ahmad Othman

Lecturer in Pharmacology

University of Nottingham

UNITED KINGDOM

Julia Williams

University of Hertfordshire

UNITED KINGDOM

Michael J. R. Desborough

UNITED KINGDOM

Tim England

Professor of Stroke Medicine

University of Nottingham

UNITED KINGDOM

Robert Dineen

Professor of Neuroradiology

University of Nottingham

UNITED KINGDOM

Peter Bath

Professor of Health Data Analytics

University of Sheffield

UNITED KINGDOM

Matthew Boyd

University of Nottingham

UNITED KINGDOM

Johannes Boltze

Professor of Neuroscience

University of Warwick

UNITED KINGDOM

Jonathan Hewitt

Cardiff University

UNITED KINGDOM

Anna Ranta

University of Otago

NEW ZEALAND

Matthew Glover

University of Surrey

UNITED KINGDOM

Malcolm Robert Macleod

Professor of Neurology and Translational Neurosciences

University of Edinburgh

UNITED KINGDOM

How do I reach out?

Meet Kite AI